Evidence map›Paper›PMID 26723257›Full record

ArticleMatrix biology : journal of the International Society for Matrix Biology2016

Inhibition of versican expression by siRNA facilitates tropoelastin synthesis and elastic fiber formation by human SK-LMS-1 leiomyosarcoma smooth muscle cells in vitro and in vivo.

Paul A Keire, Steven L Bressler, Eileen R Mulvihill, Barry C Starcher, Inkyung Kang, Thomas N Wight

Open access · greenAbstract read
In one paragraph

Article in Matrix biology : journal of the International Society for Matrix Biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. V3: an enigmatic isoform of the proteoglycan versican.American journal of physiology. Cell physiology · 2023
    Review
  3. Article
  4. Review
  5. The versican-hyaluronan complex provides an essential extracellular matrix niche for Flk1Matrix biology : journal of the International Society for Matrix Biology · 2021
    Article
  6. Article
  7. Article
  8. Elastin-driven genetic diseases.Matrix biology : journal of the International Society for Matrix Biology · 2018
    Review
  9. Article
  10. Provisional matrix: A role for versican and hyaluronan.Matrix biology : journal of the International Society for Matrix Biology · 2017
    Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Paul A KeireMatrix Biology Program, Benaroya Research Institute, 1201 Ninth Avenue, Seattle, WA 98101, USA; Department of Pathology, University of Washington, Seattle, WA 98195, USA.
Steven L BresslerMatrix Biology Program, Benaroya Research Institute, 1201 Ninth Avenue, Seattle, WA 98101, USA.
Eileen R MulvihillDepartment of Pathology, University of Washington, Seattle, WA 98195, USA.
Barry C StarcherDepartment of Biochemistry, University of Texas Health Science Center at Tyler, Tyler, TX 75708, USA.
Inkyung KangMatrix Biology Program, Benaroya Research Institute, 1201 Ninth Avenue, Seattle, WA 98101, USA.
Thomas N WightMatrix Biology Program, Benaroya Research Institute, 1201 Ninth Avenue, Seattle, WA 98101, USA; Department of Pathology, University of Washington, Seattle, WA 98195, USA. Electronic address: twight@benaroyaresearch.org.
Benaroya Research InstituteMatrix Research (United States) · USThe University of Texas Health Science Center at Tyler · USUniversity of Washington · US

Funding

Thymic Stromal Lymphopoietin (TSLP) and Lung Inflammation and ImmP01HL098067 · NHLBI · BENAROYA RESEARCH INST AT VIRGINIA MASON · PI VERNON, ROBERT B · 2010 to 2014
$13.5M
Neovasculature, Plaque Rupture And Progression by MRIP01HL072262 · NHLBI · UNIVERSITY OF WASHINGTON · PI SCHWARTZ, STEPHEN MARK · 2002 to 2006
$11.5M
Engineering vascular replacements for strength and elasticityR01EB012558 · NIBIB · BENAROYA RESEARCH INST AT VIRGINIA MASON · PI VERNON, ROBERT B, WIGHT, THOMAS N · 2011 to 2014
$2.3M
NHLBI NIH HHS HL098067NHLBI NIH HHS HL72262NHLBI NIH HHS P01 HL072262NHLBI NIH HHS P01 HL098067NIBIB NIH HHS EB012558NIBIB NIH HHS R01 EB012558
6 · The paper itself

Abstract

Versican is an extracellular matrix (ECM) molecule that interacts with other ECM components to influence ECM organization, stability, composition, and cell behavior. Versican is known to increase in a number of cancers, but little is known about how versican influences the amount and organization of the ECM components in the tumor microenvironment. In the present study, we modulated versican expression using siRNAs in the human leiomyosarcoma (LMS) smooth muscle cell line SK-LMS-1, and observed the formation of elastin and elastic fibers in vitro and also in vivo in a nude mouse tumor model. Constitutive siRNA-directed knockdown of versican in LMS cells resulted in increased levels of elastin, as shown by immunohistochemical staining of the cells in vitro, and by mRNA and protein analyses. Moreover, versican siRNA LMS cells, when injected into nude mice, generated smaller tumors that had significantly greater immunohistochemical and histochemical staining for elastin when compared to control tumors. Additionally, microarray analyses were used to determine the influence of versican isoform modulation on gene expression profiles, and to identify genes that influence and relate to the process of elastogenesis. cDNA microarray analysis and TaqMan low density array validation identified previously unreported genes associated with downregulation of versican and increased elastogenesis. These results highlight an important role for the proteoglycan versican in regulating the expression and assembly of elastin and the phenotype of LMS cells.

Indexed as

AnimalsCell LineElastic TissueGene Expression ProfilingGene Expression Regulation, NeoplasticGene Knockdown TechniquesHumansIn Vitro TechniquesLeiomyosarcomaMiceMice, NudeNeoplasm TransplantationRNA, Small InterferingTropoelastinVersicansRNA, Small InterferingTropoelastinVCAN protein, humanVcan protein, mouseVersicansElastinElastogenesisExtracellular matrixProliferationSiRNAVersican

Identifiers

PMID26723257
PMCPMC4808388
OpenAlexW2198806721

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.